1
|
Evans C: Potential biologic therapies for
the intervertebral disc. J Bone Joint Surg Am. 88(Suppl 2): 95–98.
2006. View Article : Google Scholar
|
2
|
Wehling P, Schulitz KP, Robbins PD, Evans
CH and Reinecke JA: Transfer of genes to chondrocytic cells of the
lumbar spine. Proposal for a treatment strategy of spinal disorders
by local gene therapy. Spine (Phila Pa 1976). 22:1092–1097. 1997.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Sai JM, Hu YG and Wang DC: Constructing
adeno-associated virus-TGFbeta3 and comparing its biological effect
on proteoglycan synthesis in dedifferentiated nucleus pulpous cells
with adenovirus-TGFbeta1. Chin Med Sci J. 22:113–118. 2007.
|
4
|
Wallach C, Sobajima S, Watanabe Y, et al:
Gene transfer of the catabolic inhibitor TIMP-1 increases measured
proteoglycans in cells from degenerated human intervertebral discs.
Spine (Phila Pa 1976). 28:2331–2337. 2003. View Article : Google Scholar : PubMed/NCBI
|
5
|
Lohr F, Huang Q, Hu K, Dewhirst MW and Li
CY: Systemic vector leakage and transgene expression by
intratmorally injected recombinant adenovirus vectors. Clin Cancer
Res. 7:3625–3628. 2001.PubMed/NCBI
|
6
|
Xi YM, Dong YF, Wang ZJ, Liu Y, Diao ZZ
and Hu YG: Co-transfection of adeno-associated virus-mediated human
vascular endothelial growth factor 165 and transforming growth
factor-β1 into annulus fibrosus cells of rabbit degenerative
intervertebral discs. Genet Mol Res. Feb 28–2013.(Epub ahead of
print).
|
7
|
Wallach CJ, Gilbertson LG and Kang JD:
Gene therapy applications for intervertebral disc degeneration.
Spine (Phila Pa 1976). 28:93–98. 2003. View Article : Google Scholar : PubMed/NCBI
|
8
|
Xi Y, Kong J, Liu Y, et al: Minimally
invasive induction of an early lumbar disc degeneration model in
rhesus monkeys. Spine (Phila Pa 1976). 38:E579–E586. 2013.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Nishida K, Suzuki T, Kakutani K, et al:
Gene therapy approach for disc degeneration and associated spinal
disorders. Eur Spine J. 17(Suppl 4): 459–466. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Nishida K, Kang JD, Gilbertson LG, et al:
Modulation of the biologic activity of the rabbit intervertebral
disc by gene therapy: an in vivo study of adenovirus-mediated
transfer of the human transforming growth factor beta1 encoding
gene. Spine (Phila Pa 1976). 24:2419–2425. 1999.
|
11
|
Haro H, Grawford HC, Fingleton B, et al:
Matrix metalloprotemase-3-dependent generation of a macrophage
chemoattractant in model of herniated disc resorption. J Clin
Incest. 105:133–141. 2000. View
Article : Google Scholar : PubMed/NCBI
|
12
|
Osada R, Ohshima H, Ishihara H, et al:
Autocrine/paracrine mechanism of insulin-like growth factor-1
secretion, and the effect of insulin-like growth factor-1 on
proteoglycan synthesis in bovine intervertebral discs. J Orthop
Res. 14:690–699. 1996. View Article : Google Scholar : PubMed/NCBI
|
13
|
Moon S, Nishirla K, Gilbertson LG, et al:
Biologic response of human interverterbral disc cell to gene
therapy cocktail. Spine (Phila Pa 1976). 33:1850–1855. 2008.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Imai Y, Miyamoto K, An HS, Thonar EJ,
Andersson GB and Masuda K: Recombinant human osteogenic protein-1
upregulates proteoglycan metabolism of human anulus fibrosus and
nucleus pulposus cells. Spine (Phila Pa 1976). 32:1303–1309. 2007.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Takegami K, Thonar EJ, An HS, Kamada H and
Masuda K: Osteogentic protein-1 enhances matrix replenishment by
intervertebral disc cells previously exposed to interleukin-1.
Spine (Phila Pa 1976). 27:1318–1325. 2002. View Article : Google Scholar : PubMed/NCBI
|
16
|
Masuda K, Imai Y, Okuma M, et al:
Osteogenic protein-1 injection into a degenerated disc induces the
restoration of disc height and structural changes in the rabbit
anular puncture model. Spine (Phila Pa 1976). 31:742–754. 2006.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhang Y, An HS, Song S, et al: Growth
factor osteogenic protein-1: differing effects on cells fron three
distinct zones in the bovine intervertebral disc. Am J Phys Med
Rehabil. 83:515–521. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Sive JI, Baird P, Jeziorsk M, Watkins A,
Hoyland JA and Freemont AJ: Expression of chondrocyte markers by
cells of normal and degenerate intervertebral disc. Mol Pathol.
55:91–97. 2002. View Article : Google Scholar : PubMed/NCBI
|
19
|
Paul R, Haydon RC, Cheng HW, et al:
Potential use of S0X9 gene therapy for intcrvcrtcbral degenerative
disc disease. Spine (Phila Pa 1976). 28:755–763. 2003. View Article : Google Scholar
|
20
|
Gruber HE, Norton HJ, Ingram JA and Hanley
EN Jr: The S0 transcription factor in the human disc: decreased
immunolocalization with ageand disc degeneration. Spine (Phila Pa
1976). 30:625–630. 2005. View Article : Google Scholar : PubMed/NCBI
|
21
|
Lefebvre V, Huang W, Harley VR, Goodfellow
PN and de Crombrugghe B: Sox9 is a potent activator of the
chondrocyte-specific enhancer of the proalphal(II) collagen gene.
Mol Cell Biol. 17:2336–2346. 1997.PubMed/NCBI
|
22
|
Shintani N and Hunziker EB: Chondrogenic
differentiation of bovine synovium: bone morphogenetic proteins 2
and 7 and transforming growth factor beta1 induce the formation of
different types of cartilaginous tissue. Arthritis Rheum.
56:1869–1879. 2007. View Article : Google Scholar
|